Insider Shareholders with Direct Ownership of Bio Xcel Therapeutics, Inc. (BTAI)
This section provides a comprehensive overview of the insiders with direct ownership of Bio Xcel Therapeutics, Inc. (BTAI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BioXcel Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bio Xcel Llc
> 10% Shareholder |
0 | 633,250 | 8,546,750 $5.47 Million | 2 |
Jun 25, 2021
Reduced 5.25%
|
|
Vimal Mehta
CEO and President |
322,093 | 200,384 | 51,666 $33,066 | 28 |
Sep 16, 2024
Reduced 2.18%
|
|
Frank Yocca
Chief Scientific Officer |
23,585 | 97,779 | 14,203 $9,089 | 19 |
Sep 16, 2024
Reduced 2.44%
|
|
Javier Rodriguez
Officer |
13,585 | 4,453 | 9,133 $5,845 | 16 |
Sep 16, 2024
Reduced 3.64%
|
|
Richard I Steinhart
Chief Financial Officer |
17,335 | 12,631 | 6,204 $3,970 | 18 |
Sep 16, 2024
Reduced 5.43%
|
|
Matthew T. Wiley
Chief Commercial Officer |
4,500 | 1,467 | 4,033 $2,581 | 6 |
Sep 16, 2024
Reduced 5.06%
|
|
Vincent O'Neill
Officer |
112,173 | 106,016 | 3,907 $2,500 | 20 |
Sep 16, 2024
Reduced 3.41%
|
|
Bio Xcel Holdings, Inc.
> 10% Shareholder |
160,000 | 160,000 | 0 $0 | 2 |
Jul 24, 2020
Reduced 100.0%
|
|
Krishnan Nandabalan
Director |
260,000 | 181,000 | 0 $0 | 12 |
Apr 06, 2023
Reduced 100.0%
|